Home    Back

Recombinant granulocyte - colony stimulating factor    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
39Toxic epidermal necrolysis1

39. Toxic epidermal necrolysis    [ 11 clinical trials,   18 drugs,   (DrugBank: 8 drugs),   11 drug target genes,   101 drug target pathways]
Searched query = "Toxic epidermal necrolysis", "Toxic epidermal necrosis", "TEN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 11 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02739295
(ClinicalTrials.gov)		July 20164/4/2016G-CSF in the Treatment of Toxic Epidermal NecrolysisEvaluation of G-CSF as a Treatment of Toxic Epidermal NecrolysisStevens - Johnson SyndromeDrug: recombinant granulocyte - colony stimulating factor;Drug: NaCl 0.9%University of LiegeNULLRecruiting18 YearsN/AAll10Phase 4Belgium